202 related articles for article (PubMed ID: 26017791)
1. Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway.
Liu M; Yang J; Li M
Clinics (Sao Paulo); 2015 Apr; 70(4):250-6. PubMed ID: 26017791
[TBL] [Abstract][Full Text] [Related]
2. Effect of crosstalk between Th17 and Th9 cells on the activation of dermal vascular smooth muscle cells in systemic scleroderma and regulation of tanshinone IIA.
Liu M
An Bras Dermatol; 2022; 97(6):716-728. PubMed ID: 36117047
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway.
Liu M; Yang J; Xing X; Cui X; Li M
Arthritis Res Ther; 2014 Dec; 16(6):4223. PubMed ID: 25551434
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA attenuates high glucose induced human VSMC proliferation and migration through miR-21-5p-mediated tropomyosin 1 downregulation.
Jia S; Ma WD; Zhang CY; Zhang Y; Yao ZH; Quan XH; Guo X; Wang CX
Arch Biochem Biophys; 2019 Nov; 677():108154. PubMed ID: 31672498
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis.
Jiang Y; Hu F; Li Q; Shen C; Yang J; Li M
Int Immunopharmacol; 2019 Dec; 77():105968. PubMed ID: 31704290
[TBL] [Abstract][Full Text] [Related]
6. Sodium tanshinone IIA silate inhibits high glucose-induced vascular smooth muscle cell proliferation and migration through activation of AMP-activated protein kinase.
Wu WY; Yan H; Wang XB; Gui YZ; Gao F; Tang XL; Qin YL; Su M; Chen T; Wang YP
PLoS One; 2014; 9(4):e94957. PubMed ID: 24739942
[TBL] [Abstract][Full Text] [Related]
7.
Yang GS; Zheng B; Qin Y; Zhou J; Yang Z; Zhang XH; Zhao HY; Yang HJ; Wen JK
Theranostics; 2020; 10(17):7787-7811. PubMed ID: 32685020
[No Abstract] [Full Text] [Related]
8. Tanshinone II A attenuates vascular remodeling through klf4 mediated smooth muscle cell phenotypic switching.
Lou G; Hu W; Wu Z; Xu H; Yao H; Wang Y; Huang Q; Wang B; Wen L; Gong D; Chen X; Shi Y; Yang L; Xu Y; Wang Y
Sci Rep; 2020 Aug; 10(1):13858. PubMed ID: 32807822
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via Akt/Skp2/p27-associated pathway.
Luo Y; Xu DQ; Dong HY; Zhang B; Liu Y; Niu W; Dong MQ; Li ZC
PLoS One; 2013; 8(2):e56774. PubMed ID: 23437233
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone ⅡA inhibits homocysteine-induced proliferation of vascular smooth muscle cells via miR-145/CD40 signaling.
Li Y; Chen F; Guo R; Jia S; Li W; Zhang B
Biochem Biophys Res Commun; 2020 Jan; 522(1):157-163. PubMed ID: 31757424
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA ameliorates the development of dermal fibrosis in systemic sclerosis.
Jiang Y; Hu F; Li M; Li Q
Clin Exp Pharmacol Physiol; 2024 Feb; 51(2):e13834. PubMed ID: 38037494
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA Can Inhibit Angiotensin II-Induced Proliferation and Autophagy of Vascular Smooth Muscle Cells via Regulating the MAPK Signaling Pathway.
Lu J; Shan J; Liu N; Ding Y; Wang P
Biol Pharm Bull; 2019 Nov; 42(11):1783-1788. PubMed ID: 31391347
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA from Salvia miltiorrhiza BUNGE inhibits human aortic smooth muscle cell migration and MMP-9 activity through AKT signaling pathway.
Jin UH; Suh SJ; Chang HW; Son JK; Lee SH; Son KH; Chang YC; Kim CH
J Cell Biochem; 2008 May; 104(1):15-26. PubMed ID: 17979138
[TBL] [Abstract][Full Text] [Related]
14. [Tanshinone II A inhibits in vitro cellular proliferation and migration of vascular smooth muscle cell of rabbit].
Zhang HH; Chen YC; Liang L; Zeng Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):188-92. PubMed ID: 18630680
[TBL] [Abstract][Full Text] [Related]
15. Lipophilic Extract and Tanshinone IIA Derived from
Zhang XW; Zhou M; An L; Zhang P; Li P; Chen J
Am J Chin Med; 2020; 48(6):1455-1473. PubMed ID: 32933312
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA attenuates peritoneal fibrosis through inhibition of fibrogenic growth factors expression in peritoneum in a peritoneal dialysis rat model.
Chunming J; Miao Z; Cheng S; Nana T; Wei Z; Dongwei C; Yuan F
Ren Fail; 2011; 33(3):355-62. PubMed ID: 21401363
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA Ameliorates Progression of CAD Through Regulating Cardiac H9c2 Cells Proliferation and Apoptosis by miR-133a-3p/EGFR Axis.
Xu H; Li H; Zhu P; Liu Y; Zhou M; Chen A
Drug Des Devel Ther; 2020; 14():2853-2863. PubMed ID: 32764884
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA inhibits angiotensin II-induced cell proliferation in rat cardiac fibroblasts.
Chan P; Liu JC; Lin LJ; Chen PY; Cheng TH; Lin JG; Hong HJ
Am J Chin Med; 2011; 39(2):381-94. PubMed ID: 21476213
[TBL] [Abstract][Full Text] [Related]
19. Eukaryotic elongation factor 2 kinase controls proliferation and migration of vascular smooth muscle cells.
Usui T; Nijima R; Sakatsume T; Otani K; Kameshima S; Okada M; Yamawaki H
Acta Physiol (Oxf); 2015 Feb; 213(2):472-80. PubMed ID: 25069823
[TBL] [Abstract][Full Text] [Related]
20. [Tanshinone IIa attenuates vascular calcification through inhibition of NF-κB and β-catenin signaling pathways].
Zhong H; Li DY; Wang SY; Chen JY; Chen JX; Tan X; Wang YH; Xie YC; Zhu DX
Sheng Li Xue Bao; 2022 Dec; 74(6):949-958. PubMed ID: 36594383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
